logo

For the Inventor, By the Inventor

Somerville, MA, United States of America

Ryan D White

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 262(Granted Patents)


Location History:

  • Somerville, CA (US) (2015)
  • Somerville, MA (US) (2010 - 2023)
  • Thousand Oaks, CA (US) (2023 - 2024)

Company Filing History:

goldMedal34 out of 1,974 
 
Amgen Inc.
 patents
silverMedal7 out of 7 
 
Vigil Neuroscience, Inc.
 patents
bronzeMedal2 out of 125 
 
Teijin Pharma Limited
 patents
4. 1 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents
1. 12428425 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-09-30),
2. 12319691 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-06-03),
3. 12252489 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2025-03-18),
4. 11912711 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2024-02-27),
5. 11884675 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2024-01-30),
6. 11718617 - Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use (2023-08-08),
7. 11608344 - Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use (2023-03-21),
8. 11572374 - N-cyano-7-azanorbornane derivatives and uses thereof (2023-02-07),
9. 11332459 - Benzimidazole derivatives and their uses (2022-05-17),
10. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-10-03),
11. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-08-08),
12. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-04-04),
13. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),
14. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),
15. 9365522 - Pyrazole amide derivative (2016-06-14),

Title: The Innovative Achievements of Inventor Ryan D White

Introduction:

Inventor Ryan D White, based in Somerville, MA, has made significant contributions to the field of medical research with a notable portfolio of 31 patents.

Latest Patents:

White's recent patents focus on heterocyclic compounds as triggering receptor expressed on myeloid cells 2 (TREM2) agonists. These compounds demonstrate utility in the activation of TREM2 and the treatment of neurodegenerative disorders. Pharmaceutical compositions and synthesis intermediates are also disclosed in these patents.

Career Highlights:

With a background in medical research, White has made substantial strides in advancing treatments for neurodegenerative disorders. He has a keen focus on utilizing innovative compounds to target specific biological receptors for therapeutic purposes.

Collaborations:

During his career, White has collaborated with esteemed companies such as Amgen Inc. and Teijin Pharma Limited. His collaborative efforts with individuals like Jason Brooks Human and Oleg Epstein have resulted in groundbreaking research and patent developments.

Conclusion:

In conclusion, Ryan D White's dedication to medical research and innovation is evident in his extensive patent portfolio. His contributions in the field of pharmaceuticals and neurodegenerative disorder treatments continue to pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…